Ipamorelin

Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) derived from the earlier growth-hormone-releasing peptide GHRP-1, studied as a selective growth-hormone secretagogue in endocrine research. It is supplied by NOX as a lyophilised research reference material for research use only; the information here is educational and not guidance for any human, clinical or veterinary application.

Ipamorelin binds the growth-hormone-secretagogue receptor (the ghrelin receptor, GHS-R1a) on pituitary somatotroph cells, triggering growth-hormone release. Its defining feature in the literature is selectivity: unlike older secretagogues such as GHRP-2 or GHRP-6, it prompts little change in cortisol, prolactin or appetite-related signalling. This is mechanistic research context; the compound is supplied for research use only.

Ipamorelin is most often examined in growth-hormone-secretagogue and endocrine-signalling research using cell and preclinical models, including work on pulsatile GH release and receptor selectivity, where the focus is mechanism rather than any applied result. As a NOX research reference material, Ipamorelin is supplied for research use only and is not associated with any therapeutic use.

Lyophilised Ipamorelin is supplied as a sealed, freeze-dried powder and is generally kept frozen and away from light, typically stored at around -20°C for long-term stability, while for shorter periods it can be kept in the fridge at 2–8°C. Keeping the vial sealed limits moisture uptake and helps preserve the dry material. This describes general laboratory handling of lyophilised research compounds and is provided for research use only, not as guidance for any other use.

Lyophilisation freeze-dries the material into a dry powder that is considerably more stable than a solution and tolerates storage and shipping far better. This is why research compounds such as Ipamorelin are supplied lyophilised and reconstituted only when a study requires. The description is educational; the material is supplied strictly for research use only.

Ipamorelin is supplied as a lyophilised powder in 10 mg and 5 mg. The stated strength is the mass of compound sealed in the vial before reconstitution; the working concentration depends on the volume of solvent a researcher adds during preparation. All presentations are research reference materials supplied for research use only.

Bacteriostatic water is commonly used to reconstitute lyophilised research compounds because the small amount of benzyl alcohol it contains helps limit microbial growth in a multi-use vial. It simply dissolves the freeze-dried powder into a liquid so the material can be handled in the laboratory. Reconstitution is performed strictly within a research context; Ipamorelin is supplied by NOX for research use only.

Once reconstituted, Ipamorelin is in solution and generally less stable than the dry powder, so the liquid is typically kept in the fridge at 2–8°C and protected from light. Researchers usually prepare only what a study requires and record the reconstitution date. This reflects general laboratory handling of reconstituted research materials and is offered for research-use-only context, not as guidance for human or veterinary use.

Yes. Ipamorelin is supplied by NOX strictly as a research reference material for laboratory and analytical use. It is not a medicinal product, food, cosmetic or veterinary product, and nothing in these answers should be read as guidance for human or animal use. All information here is provided for educational and research context only.